ALLUCENT (PL) SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

TAX ID1132288234

KRS0000027834

Share capital50,000.00 zł

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

UL. POSTĘPU 17B, 02-676 WARSZAWA

Show on map

Is this your company?Update company information to get new customers, get notified of new reviews, and more!

Register Data

Full name

ALLUCENT (PL) SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

UL. POSTĘPU 17B, 02-676 WARSZAWA

Show on map

NIP

1132288234

REGON

017219863

KRS

0000027834

Legal form

limited liability company

Register Address

UL. POSTĘPU 17B, 02-676 WARSZAWA

Date of registration in KRS

2001-07-13

Date of commencement of economic activity

2001-07-13

Act signature

WA.XIII NS-REJ.KRS/65586/23/887/ADE

Pkd codes

70.22.Z - Head office activities and management consultancy

46.46.Z - Wholesale trade of pharmaceutical and medical products

47.73.Z - Retail sale of pharmaceutical products

72.19.Z - Scientific research and development activities

Payer VAT status

Active

Vat list bank account(s)

PL90 1030 1508 0000 0008 2368 2000

PL63 1030 1508 0000 0008 2368 2001

PL33 1030 1335 0000 0008 2368 2500

Company authorities

representation authorityTHE COMPANY'S MANAGEMENT

supervisory authorityboard of directors

representation type

CZŁONEK ZARZĄDU SAMODZIELNIE

THE COMPANY'S MANAGEMENT

Christopher Brennan

Member Of The Board

Sławomir Dębicki

Member Of The Board, 58 years old

shareholders

ALLUCENT (UK) LIMITED

100% 100 udziałów o łącznej wartości 50.000 złotych

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2021	2022	2023
	M PLN	M PLN	M PLN	%
Profit (loss) on sale	0,4	0,7	0,5	-27,6
Gross profit (loss)	0,4	0,6	0,4	-33
EBITDA	0,5	0,7	0,6	-21,1
Short time liabilities	1,6	1,5	0,7	-54,9
Other operating costs	0	0	0	517,1
Equity capital	6,7	7,1	7,4	3,7
Operating profit (EBIT)	0,4	0,7	0,5	-29,3
Assets	8,3	8,6	8,1	-6,2
Net profit (loss)	0,3	0,4	0,3	-37,7
Cash	0,3	0,1	0,8	1243,3
Liabilities and provisions for liabilities	1,6	1,5	0,7	-54,9
Net income from sale	14,7	17,4	14,7	-15,8
Working assets	8	8,4	7,9	-6,3
Other income costs	0	0	0	129,9
Depreciation	0	0	0,1	97
	%	%	%	p.p.
Profitability of capital	4,5	6	3,6	-2,4
Equity capital to total assets	81,2	83,1	91,9	8,8
Gross profit margin	2,8	3,5	2,8	-0,7
EBITDA Margin	3,1	4,2	3,9	-0,3
	Days	Days	Days	Days
Short term commitment turnover cycle	39	31	16	-15

Current financial liquidity indicator	5.18638277053833	5.764477729797363	11.989449501037598	6,2
Net dept to EBITDA	-0.5833677053451538	-0.085042804479599	-1.4486668109893799	-1,3